These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35447688)

  • 61. Integrated continuous biomanufacturing platform with ATF perfusion and one column chromatography operation for optimum resin utilization and productivity.
    Kamga MH; Cattaneo M; Yoon S
    Prep Biochem Biotechnol; 2018 May; 48(5):383-390. PubMed ID: 29509101
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells.
    Wu Y; Bissinger T; Genzel Y; Liu X; Reichl U; Tan WS
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1421-1434. PubMed ID: 33515287
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Repurposing fed-batch media and feeds for highly productive CHO perfusion processes.
    Kuiper M; Spencer C; Fäldt E; Vuillemez A; Holmes W; Samuelsson T; Gruber D; Castan A
    Biotechnol Prog; 2019 Jul; 35(4):e2821. PubMed ID: 30985083
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of cysteine, asparagine, or glutamine limitations in Chinese hamster ovary cell batch and fed-batch cultures.
    Ghaffari N; Jardon MA; Krahn N; Butler M; Kennard M; Turner RFB; Gopaluni B; Piret JM
    Biotechnol Prog; 2020 Mar; 36(2):e2946. PubMed ID: 31823468
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Optimizing capacity utilization by large scale 3000 L perfusion in seed train bioreactors.
    Pohlscheidt M; Jacobs M; Wolf S; Thiele J; Jockwer A; Gabelsberger J; Jenzsch M; Tebbe H; Burg J
    Biotechnol Prog; 2013; 29(1):222-9. PubMed ID: 23225663
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative study of commercial media to improve GMP manufacturing of recombinant human interferon β-1a by CHO cells in perfusion bioreactor.
    Sedighikamal H; Karimi Mostofi R; Sattarzadeh A; Shahbazi M; Aghazadeh H
    Cytotechnology; 2022 Dec; 74(6):669-680. PubMed ID: 36389287
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bax and Bak knockout apoptosis-resistant Chinese hamster ovary cell lines significantly improve culture viability and titer in intensified fed-batch culture process.
    Tang D; Lam C; Bauer N; Auslaender S; Snedecor B; Laird MW; Misaghi S
    Biotechnol Prog; 2022 Mar; 38(2):e3228. PubMed ID: 34951158
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment.
    Huang YM; Hu W; Rustandi E; Chang K; Yusuf-Makagiansar H; Ryll T
    Biotechnol Prog; 2010; 26(5):1400-10. PubMed ID: 20945494
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Process development for a recombinant Chinese hamster ovary (CHO) cell line utilizing a metal induced and amplified metallothionein expression system.
    Huang EP; Marquis CP; Gray PP
    Biotechnol Bioeng; 2004 Nov; 88(4):437-50. PubMed ID: 15459913
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Process development for an inducible rituximab-expressing Chinese hamster ovary cell line.
    Mellahi K; Cambay F; Brochu D; Gilbert M; Perrier M; Ansorge S; Durocher Y; Henry O
    Biotechnol Prog; 2019 Jan; 35(1):e2742. PubMed ID: 30414355
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Application of dielectric spectroscopy for monitoring high cell density in monoclonal antibody producing CHO cell cultivations.
    Párta L; Zalai D; Borbély S; Putics A
    Bioprocess Biosyst Eng; 2014 Feb; 37(2):311-23. PubMed ID: 23801499
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stress-induced increase of monoclonal antibody production in CHO cells.
    Schellenberg J; Nagraik T; Wohlenberg OJ; Ruhl S; Bahnemann J; Scheper T; Solle D
    Eng Life Sci; 2022 May; 22(5):427-436. PubMed ID: 35573136
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Investigation into the impact of tyrosine on the product formation and quality attributes of mAbs in rCHO cell cultures.
    Zhang W; Liu X; Tang H; Zhang X; Zhou Y; Fan L; Wang H; Tan WS; Zhao L
    Appl Microbiol Biotechnol; 2020 Aug; 104(16):6953-6966. PubMed ID: 32577803
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of various pine needle extracts on Chinese hamster ovary cell growth and monoclonal antibody quality.
    Zhang D; Qiu J; Niu QT; Liu T; Gu R; Zhang X; Luo S
    Prep Biochem Biotechnol; 2023 Oct; 53(9):1081-1091. PubMed ID: 36756987
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Selection of chemically defined media for CHO cell fed-batch culture processes.
    Pan X; Streefland M; Dalm C; Wijffels RH; Martens DE
    Cytotechnology; 2017 Feb; 69(1):39-56. PubMed ID: 27900626
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-cell-density cultivations to increase MVA virus production.
    Vázquez-Ramírez D; Genzel Y; Jordan I; Sandig V; Reichl U
    Vaccine; 2018 May; 36(22):3124-3133. PubMed ID: 29433897
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sustaining an efficient and effective CHO cell line development platform by incorporation of 24-deep well plate screening and multivariate analysis.
    Mora A; Zhang SS; Carson G; Nabiswa B; Hossler P; Yoon S
    Biotechnol Prog; 2018 Jan; 34(1):175-186. PubMed ID: 29150912
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bioprocess development for the production of mouse-human chimeric anti-epidermal growth factor receptor vIII antibody C12 by suspension culture of recombinant Chinese hamster ovary cells.
    Hu S; Deng L; Wang H; Zhuang Y; Chu J; Zhang S; Li Z; Guo M
    Cytotechnology; 2011 May; 63(3):247-58. PubMed ID: 21298341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.